title: A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial.
authors.affiliation: Department of Medicine, New England Medical Center, Boston, MA 02111.
authors.forename: D R
authors.initials: DR
authors.lastname: Snydman
authors.forename: B G
authors.initials: BG
authors.lastname: Werner
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
authors.forename: R L
authors.initials: RL
authors.lastname: Kirkman
authors.forename: E L
authors.initials: EL
authors.lastname: Milford
authors.forename: S I
authors.initials: SI
authors.lastname: Cho
authors.forename: H L
authors.initials: HL
authors.lastname: Bush
authors.forename: A S
authors.initials: AS
authors.lastname: Levey
authors.forename: T B
authors.initials: TB
authors.lastname: Strom
authors.forename: C B
authors.initials: CB
authors.lastname: Carpenter
mesh_terms: D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000009:adverse effects; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology; D011446:Prospective Studies; D011897:Random Allocation; D013577:Syndrome
chemical_list: D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin